Centene Corp banner

Centene Corp
NYSE:CNC

Watchlist Manager
Centene Corp Logo
Centene Corp
NYSE:CNC
Watchlist
Price: 43.32 USD -0.76% Market Closed
Market Cap: $21.3B

Relative Value

The Relative Value of one CNC stock under the Base Case scenario is hidden USD. Compared to the current market price of 43.32 USD, Centene Corp is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CNC Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

Multiples Across Competitors

CNC Competitors Multiples
Centene Corp Competitors

All Multiples
P/S
P/E
P/B
All Countries
Close
Market Cap P/S P/E P/B
US
Centene Corp
NYSE:CNC
21.3B USD 0.1 -3.2 1.1
US
UnitedHealth Group Inc
NYSE:UNH
258.3B USD 0.6 21.4 2.6
US
Anthem Inc
LSE:0HG8
72.5B USD 0.4 12.8 1.6
US
Elevance Health Inc
NYSE:ELV
62B USD 0.3 10.9 1.4
US
Humana Inc
NYSE:HUM
21.5B USD 0.2 18.1 1.2
US
Molina Healthcare Inc
NYSE:MOH
7.4B USD 0.2 15.8 1.8
US
Healthequity Inc
NASDAQ:HQY
6.9B USD 5.3 35.7 3.2
US
Magellan Health Inc
F:MAH1
2.2B EUR 0.5 8.5 1.3
US
Progyny Inc
NASDAQ:PGNY
1.5B USD 1.2 25.5 2.9
BR
Odontoprev SA
BOVESPA:ODPV3
7.5B BRL 3.1 12.8 5.8
US
Clover Health Investments Corp
NASDAQ:CLOV
1B USD 0.6 -17.5 3
P/E Multiple
Earnings Growth PEG
US
Centene Corp
NYSE:CNC
Average P/E: 17.9
Negative Multiple: -3.2
N/A N/A
US
UnitedHealth Group Inc
NYSE:UNH
21.4
21%
1
US
A
Anthem Inc
LSE:0HG8
12.8
11%
1.2
US
Elevance Health Inc
NYSE:ELV
10.9
11%
1
US
Humana Inc
NYSE:HUM
18.1
37%
0.5
US
Molina Healthcare Inc
NYSE:MOH
15.8
19%
0.8
US
Healthequity Inc
NASDAQ:HQY
35.7
69%
0.5
US
M
Magellan Health Inc
F:MAH1
8.5
N/A N/A
US
Progyny Inc
NASDAQ:PGNY
25.5
35%
0.7
BR
Odontoprev SA
BOVESPA:ODPV3
12.8
4%
3.2
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -17.5 N/A N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett